CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve ...
CleaRecon DL* is designed to improve cone-beam computed tomography (CBCT) image quality by removing streaks and help clinicians improve their confidence in image interpretation when analyzing CBCT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results